ORGO · NASDAQ · Drug Manufacturers - Specialty & Generic

Organogenesis

Develops regenerative products for advanced wound care, surgery, and sports medicine.

$1.74
After-hours close+0.00 (+0.29%)
At close$1.74(−0.29%)
DateEstimateReportedSurprise
Nov 2026−$0.18
Aug 2026−$0.35−$0.71−102.9%
May 2026−$0.29−$0.37−27.6%
Feb 2026$0.22$0.31+44.2%
Nov 2025$0.21$0.18−14.3%

The latest year is open to everyone — the 38 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Feb 2025
Nov 2024
Aug 2024
May 2024
Feb 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Nov 2020
Aug 2020
May 2020
Mar 2020
Nov 2019
Aug 2019
May 2019
Mar 2019
Nov 2018
Aug 2018
May 2018
Mar 2018
Nov 2017
Aug 2017
May 2017
Mar 2017
Nov 2016
Jun 2016
Mar 2016
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 5, 2026−$0.18$52.1M
Aug 6, 2026−$0.35−$0.71−102.9%$54.3M$43.8M−19.4%
May 7, 2026−$0.29−$0.37−27.6%$43.3M$36.3M−16.2%
Feb 26, 2026$0.22$0.31+44.2%$172.7M$225.1M+30.4%
Nov 6, 2025$0.21$0.18−14.3%$172.7M$150.9M−12.6%

The latest year is open to everyone — the 38 quarters behind it read with an account.

Sign in
Aug 7, 2025
May 8, 2025
Feb 27, 2025
Nov 12, 2024
Aug 8, 2024
May 9, 2024
Feb 29, 2024
Nov 9, 2023
Aug 9, 2023
May 10, 2023
Mar 1, 2023
Nov 9, 2022
Aug 9, 2022
May 10, 2022
Mar 1, 2022
Nov 9, 2021
Aug 9, 2021
May 10, 2021
Mar 16, 2021
Nov 9, 2020
Aug 10, 2020
May 11, 2020
Mar 9, 2020
Nov 12, 2019
Aug 9, 2019
May 10, 2019
Mar 18, 2019
Nov 9, 2018
Aug 7, 2018
May 10, 2018
Mar 14, 2018
Nov 14, 2017
Aug 11, 2017
May 12, 2017
Mar 28, 2017
Nov 18, 2016
Jun 30, 2016
Mar 31, 2016